NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The 13% look like they are effectively cured. That's not the standard for approval of new cancer drugs. I f it were, there would be no other drugs approved in this space or virtually any other cancer space and drugs like Keytruda, would not even be on the market for most cancers.

Don't let people trick you into arguing on false framing of the question.

There is a survival benefit across the entire population treated. There are especially good results for many patients who typically do poorly. They have a survival benefit out of this world for the 13%, which is completely beyond what would normally be expected for an approved drug.

And lastly, they have indicia that combinations, as with poly-iclc and potentially adding also Keytruda ultimately, there will be a much larger expansion of patients living longer and without recurrence to a level typically unheard of for brain cancer and even generally for many other cancers.

That anyone has people freaking out and fearing with this kind of data, speaks to the power of misinformation and disinformation, repeatedly posted, to create false impressions.